Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC).

Salgia R, Pharaon R, Mambetsariev I, Nam A, Sattler M. The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC). Cell Rep Med. 2021 Jan 19; 2(1):100186.

View in: PubMed

collapse authors with profiles